StockData
IGC Pharma, Inc. logo

IGC Pharma, Inc. (IGC) income statement

IGCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 2/3017% above fair value
$0.18−0.01 (-5.45%)

Close on Nov 19, 2026Market cap $19.02MP/E –Yield –

See a number that looks wrong?